Skip to main content
SpringerLink
Log in

The Role of Point-of-Care Anticoagulation Monitoring in Arterial and Venous Thromboembolic Disorders

  • Published:
Journal of Thrombosis and Thrombolysis Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Olson JD, Arkin CF, Brandt JT, Cunningham MT, Giles A, Koepke JA, et al. College of american pathologists conference XXXI on laboratory monitoring of anticoagulant therapy: Laboratory monitoring of unfractionated heparin therapy. Arch Pathol Lab Med 1998;122:782–798.

    Google Scholar 

  2. Becker RC, Cyr J, Corrao JM, Ball SP. Bedside coagulation monitoring in heparin-treated patients with active thromboembolic disease: a coronary care unit experience. Am Heart J 1994;128:719–723.

    Google Scholar 

  3. Becker RC, Ball SP, Eisenberg P, Borzak S, Held AC, Spencer F, et al. A randomized, multicenter trial of weight-adjusted intravenous heparin dose titration and point-of-care coagulation monitoring in hospitalized patients with active thromboembolic disease. Am Heart J 1999;137;137:59–71.

    Google Scholar 

  4. Raschke RA, Reilly BM, Guidry JR, Fontana JR, Srinivas S. The weight-based heparin dosing nomogram compared with a “standard care” nomogram. Ann Intern Med 1993; 119:874–881.

    Google Scholar 

  5. Zabel KM, Granger CB, Becker RC, Bovill EG, Hirsh J, Aylward PE, et al. Use of bedside activated partial thromboplastin timemonitor to adjust heparin dosing after thrombolysis for acute myocardial infarction: Results of GUSTO-I. Am Heart J 1998;136:868–876.

    Google Scholar 

  6. aPTT policies and procedures from CoaguCheck Plus Policy and Procedure Manual. Boehringer Mannheim Diagnostic; 1995.

  7. Ansell J, Holden A, Knapic N. Patient self-management of oral anticoagulation guided by capillary (fingerstick) whole blood prothrombin times. Ann Intern Med 1989;149:2509–2511.

    Google Scholar 

  8. White RH, Becker DM, Gunther-Macer G. Outpatient use of a portable international normalized ratio/prothrombin time monitor. South Med J 1994;87:206–210.

    Google Scholar 

  9. Reiner JS, Coyne KS, Lundergan CF, Ross AM. Bedside monitoring of heparin therapy: Comaprison of activated clotting time to activated partial thromboplastin time. Cathet Cardiovasc Diag 1994;32:49–52.

    Google Scholar 

  10. Massicotte P, Marzinotto V, Vegh P, Adams M, Andrew M. Home monitoring of warfarin in children with a whole blood prothrombin time monitor. J Pediatr 1995;127:389–394.

    Google Scholar 

  11. Ruzicka K, Kapiotis S, Quehenberger P, Handler S, Hornykewycz S, Michitsch A, et al. Evaluation of bedside prothrombin time and activated partial thromboplastin time measurement by coagulation analyzer coagucheck plus in various clinical settings. Thromb Res 1997;87:431–440.

    Google Scholar 

  12. Despotis GJ, Santoro SA, Spitznagel E, Kater KM, Barnes P, Cox JL, et al. On-site prothrombin time, activated partial thromboplastin time, and platelet count. Anesthesiology 1994;80:338–351.

    Google Scholar 

  13. Nuttall GA, Oliver WC, Beynen FM, Dull JJ, Murray MJ, Nichols WL. Intraoperative measurement of activated partial thromboplastin time and prothrombin time by a portable laser photometer in patients following cardiopulmonary bypass. J Cardiothorac Vasc Anesth 1993;7:402–409.

    Google Scholar 

  14. Vacek JL, Hibiya K, Rosamond TL, Kramer PH, Beauchamp GD. Validation of a bedside method of activated partial thromboplastin time measurement with clinical range guidelines. Am J Cardiol 1991;68:557–559.

    Google Scholar 

  15. Despotis GJ, Hogue CW, Santoro SA, Joist JH, Barnes PW, Lappas DG. Effect of heparin on whole blood activated partial thromboplastin time using a portable, whole blood coagulation monitor. Crit Care Med 1995;23:1674–1679.

    Google Scholar 

  16. Samama CM, Quezada R, Riou B, Mourgeon E, Arock M, Ankri A, et al. Intraoperative measurement of activated partial thromboplastin time and prothrombin time with a new compact monitor. Acta Anaesthesiol Scand 1994;38: 232–237.

    Google Scholar 

  17. Anderson DR, Harrison L, Hirsh J. Evaluation of a portable prothrombin time monitor for home use by patients who require long-term oral anticoagulation therapy. Arch Intern Med 1993;153:1441–1447.

    Google Scholar 

  18. Linder R, Grip L, Olason E, Blomback M. Bedside heparin monitoring by activate partial thromboplastin timemeasure with a dry reagent. Clin Chem 1996;42:1488–1489.

    Google Scholar 

  19. McCurdy SA, White RH. Accuracy and precision of a portable anticoagulation monitor in a clinical setting. Arch Intern Med 1992;152:589–592.

    Google Scholar 

  20. Ansell J, Tiarks C, Hirsh J, McGehee W, Adler D, Weibert R. Measurement of the activated partial thromboplastin time from a capillary (fingerstick) sample of whole blood. Am J Clin Pathol 1991;95:222–227.

    Google Scholar 

  21. Reich DL, Yanakakis MJ, Vela-Cantos FP, DePerio M, Jacobs E. Comparison of bedside coagulation monitoring tests with standard laboratory tests in patients after cardiac surgery. Anesth Analg 1993;77:673–679.

    Google Scholar 

  22. Lucas FV, Duncan A, Jay R, Coleman R, Craft P, Vhan B et al. A novel whole blood capillary technic for measuring the prothrombin time. Am J Clin Pathol 1987;88:442–446.

    Google Scholar 

  23. O'Neill AI, McAllister C, Corke CF, Parkin JD. A comparison of five devices for the bedside monitoring of heparin therapy. Anaesth Intens Care 1991;19:592–601.

    Google Scholar 

  24. Kaatz SS, White RH, Hill J, Mascha E, Humphries JE, Becker DM. Accuracy of laboratory and portable monitor international normalized ratio determinations. Arch Intern Med 1995;155:1861–1867.

    Google Scholar 

  25. Werner M, Gallagher JV, Ballo MS, Karcher DS. Effect of analytic uncertainty of conventional and point-of-care assays of activated partial thromboplastin time on clinical decisions in heparin therapy. Am J Clin Pathol 1994;102:237–241.

    Google Scholar 

  26. Despotis GJ, Santoro SA, Spitznagel E, Kater KM, Cox JL, Barnes P, et al. Prospective evaluation and clinical utility of on-site monitoring of coagulation in patients undergoing cardiac operation. J Thorac Cardiovasc Surg 1994;107:271–279.

    Google Scholar 

  27. Weibert RT, Adler DS. Evaluation of a capillary whole-blood prothrombin time measurement system. Clin Pharm 1989; 8:864–867.

    Google Scholar 

  28. Tripodi A, Arbini AA, Chantarangkul V, Bettega D, Mannucci PM. Are capillary whole blood coagulation monitors suitable for the control of oral anticoagulant treatment by the international normalized ratio. Thromb and Haemost 1993;70:921–924.

    Google Scholar 

  29. Taylor CT, Petros WP, Ortel TL. Two instruments to determine activated partial thromboplastin time: implications for heparin monitoring. Pharmacotherapy 1999;19:383–387.

    Google Scholar 

  30. Le DT, Weibert R, Sevilla BK, Donnelly KJ, Rapaport SI. The international normalized ratio (INR) for monitoring warfarin therapy: Reliability and relation to other monitoring methods. Ann Intern Med 1994;120:552–558.

    Google Scholar 

  31. Ray MJ, Carroll PA, Just SJE, Hawson GAT, Bett JHN. The effect of oral anticoagulant therapy on aPTT results from a bedside coagulation monitor. J Clin Monit 1994;10:97–100.

    Google Scholar 

  32. Clinical Studies Group. Comparison of two sampling methodologies for obtaining aPTT samples: Heparinized radial arterial catheters and venipuncture. Mountain View, CA: Biotrack, Inc

  33. Fairweather RB, Ansell J, Anton M, Van den Besselaar HO, Brandt JT, Bussey HI, et al. College of american pathologists conference XXXI on laboratory monitoring of anticoagulant therapy: Laboratory monitoring of oral anticoagulant therapy. Arch Pathol Lab Med 1998;122:768–781.

    Google Scholar 

  34. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986;1:307–310.

    Google Scholar 

  35. Ansell JE, Jamke AK, Holden A, Knapic N. Cost effectiveness of monitoring warfarin therapy using standard versus capillary prothrombin times. Am J Clin Pathol 1989;91: 587–589.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Henry Ford Hospital, Department of Pharmacy Services, Detroit, MI

    Christopher R. Zimmerman

Authors
  1. Christopher R. Zimmerman
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Christopher R. Zimmerman.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Zimmerman, C.R. The Role of Point-of-Care Anticoagulation Monitoring in Arterial and Venous Thromboembolic Disorders. J Thromb Thrombolysis 9, 187–198 (2000). https://doi.org/10.1023/A:1018744124955

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1018744124955

Search

Navigation